Financial Connections Group’s Prime Medicine PRME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12K Hold
3,712
﹤0.01% 180
2025
Q4
$12K Hold
3,712
﹤0.01% 172
2025
Q3
$20K Buy
+3,712
New +$15.1K 0.01% 143

Other funds holding PRME

Financial Connections Group's PRME Position: Q1 2026 in Review

Financial Connections Group held its Prime Medicine (PRME) position steady in Q1 2026 at 3,712 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #180.

Financial Connections Group first reported a position in PRME in Q3 2025 and has held it in 3 quarters since. The position peaked at $20K in Q3 2025. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Financial Connections Group held 3,712 shares of Prime Medicine worth $12K as of Q1 2026.
  • Financial Connections Group left its Prime Medicine share count unchanged in Q1 2026.
  • Prime Medicine made up ﹤0.01% of Financial Connections Group's portfolio in Q1 2026, its #180 holding.
  • Financial Connections Group first reported a position in Prime Medicine in Q3 2025 and has held it in 3 quarters since.
  • Financial Connections Group's Prime Medicine position peaked at $20K in Q3 2025.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Financial Connections Group's 13F filing for Q1 2026, filed 1 May 2026.